NEXEL
Seoul
About NEXEL
NEXEL is a biotechnology research firm that specializes in the advancement of drugs, biotherapeutics, and iPSC technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $27.0M
- Last round: Series Unknown (Apr 2023)
- Website: nexel.co.kr
- Phone: +82-2-2088-8886
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/nexel-93229 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.